User profiles for G. CAMBRIDGE
Graeme CambridgeUniversity of Toronto Verified email at chem.utoronto.ca Cited by 1692 |
B-cell targeting in rheumatoid arthritis and other autoimmune diseases
JCW Edwards, G Cambridge - Nature Reviews Immunology, 2006 - nature.com
… In patients with autoimmune disease, approximately 2–3 g of rituximab in total is given as a
series … Cambridge, G. et al. Serological changes following B lymphocyte depletion therapy for …
series … Cambridge, G. et al. Serological changes following B lymphocyte depletion therapy for …
Sustained improvement in rheumatoid arthritis following a protocol designed to deplete B lymphocytes
JCW Edwards, G Cambridge - Rheumatology, 2001 - academic.oup.com
Objectives. An open study of B‐lymphocyte depletion was undertaken in rheumatoid
arthritis (RA) patients to test the hypothesis that B lymphocytes may be essential to disease …
arthritis (RA) patients to test the hypothesis that B lymphocytes may be essential to disease …
An open study of B lymphocyte depletion in systemic lupus erythematosus
MJ Leandro, JC Edwards, G Cambridge… - Arthritis & …, 2002 - Wiley Online Library
Objective To gain preliminary evidence for the safety and efficacy of B lymphocyte depletion
therapy in refractory systemic lupus erythematosus (SLE). Methods Six female patients with …
therapy in refractory systemic lupus erythematosus (SLE). Methods Six female patients with …
Reconstitution of peripheral blood B cells after depletion with rituximab in patients with rheumatoid arthritis
MJ Leandro, G Cambridge… - … : Official Journal of …, 2006 - Wiley Online Library
Objective To study the quantitative and phenotypic reconstitution of peripheral blood B cells
and its relationship to the dynamics of clinical response in patients with rheumatoid arthritis (…
and its relationship to the dynamics of clinical response in patients with rheumatoid arthritis (…
Serologic changes following B lymphocyte depletion therapy for rheumatoid arthritis
G Cambridge, MJ Leandro… - … : Official Journal of …, 2003 - Wiley Online Library
Serologic changes following B lymphocyte depletion therapy for rheumatoid arthritis -
Cambridge - 2003 - Arthritis & Rheumatism - Wiley Online Library … Geraldine Cambridge PhD …
Cambridge - 2003 - Arthritis & Rheumatism - Wiley Online Library … Geraldine Cambridge PhD …
B-cell depletion in the treatment of patients with systemic lupus erythematosus: a longitudinal analysis of 24 patients
MJ Leandro, G Cambridge, JC Edwards… - …, 2005 - academic.oup.com
Objectives. To assess the clinical and basic serological consequences of B-cell depletion
with rituximab in the treatment of patients with systemic lupus erythematosus (SLE) who have …
with rituximab in the treatment of patients with systemic lupus erythematosus (SLE) who have …
Clinical outcome in 22 patients with rheumatoid arthritis treated with B lymphocyte depletion
…, JCW Edwards, G Cambridge - Annals of the rheumatic …, 2002 - ard.bmj.com
Objectives: To obtain evidence for dose response and to extend evidence of safety and
efficacy for B lymphocyte depletion in rheumatoid arthritis. Methods: Twenty two patients with …
efficacy for B lymphocyte depletion in rheumatoid arthritis. Methods: Twenty two patients with …
Complex and hierarchical micelle architectures from diblock copolymers using living, crystallization-driven polymerizations
T Gädt, NS Ieong, G Cambridge, MA Winnik… - Nature materials, 2009 - nature.com
… 1g), which indicates that the platelet edges are not densely covered with a PI brush layer
but are available for epitaxial growth. The selective nature of the growth from the faces at the …
but are available for epitaxial growth. The selective nature of the growth from the faces at the …
A retrospective seven‐year analysis of the use of B cell depletion therapy in systemic lupus erythematosus at university college london hospital: the first fifty patients
TYT Lu, KP Ng, G Cambridge… - Arthritis Care & …, 2009 - Wiley Online Library
… A previous study by Cambridge et al (14) showed that antipneumococcal responses are
preserved after 1 cycle of BCDT in patients with SLE for at least 1 year. Two other adverse …
preserved after 1 cycle of BCDT in patients with SLE for at least 1 year. Two other adverse …
Circulating levels of B lymphocyte stimulator in patients with rheumatoid arthritis following rituximab treatment: relationships with B cell depletion, circulating antibodies …
G Cambridge, W Stohl, MJ Leandro… - Arthritis & …, 2006 - Wiley Online Library
… Pretreatment serum anti-CCP antibody levels were elevated (>200 IU/ml) in 7 of the 10
patients tested (Figure 1G). Although they visually paralleled the changes in RF levels, the …
patients tested (Figure 1G). Although they visually paralleled the changes in RF levels, the …